0001401708-21-000125.txt : 20210419
0001401708-21-000125.hdr.sgml : 20210419
20210419161735
ACCESSION NUMBER: 0001401708-21-000125
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210415
FILED AS OF DATE: 20210419
DATE AS OF CHANGE: 20210419
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERSHBERG ROBERT
CENTRAL INDEX KEY: 0001274139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35980
FILM NUMBER: 21834811
MAIL ADDRESS:
STREET 1: 3005 FIRST AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NanoString Technologies Inc
CENTRAL INDEX KEY: 0001401708
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 200094687
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-378-6266
MAIL ADDRESS:
STREET 1: 530 FAIRVIEW AVENUE NORTH
CITY: SEATTLE
STATE: WA
ZIP: 98109
4
1
wf-form4_161886343330491.xml
FORM 4
X0306
4
2021-04-15
0
0001401708
NanoString Technologies Inc
NSTG
0001274139
HERSHBERG ROBERT
C/O NANOSTRING TECHNOLOGIES, INC.
530 FAIRVIEW AVENUE N
SEATTLE
WA
98109
1
0
0
0
Common Stock
2021-04-15
4
M
0
144
14.71
A
2034
D
Common Stock
2021-04-15
4
S
0
7
71.75
D
2027
D
Common Stock
2021-04-15
4
S
0
19
72.87
D
2008
D
Common Stock
2021-04-15
4
S
0
118
74.20
D
1890
D
Stock Option (right to buy)
14.71
2021-04-15
4
M
0
144
14.71
D
2025-12-31
Common Stock
144.0
7684
D
The sales reported by Dr. Hershberg were effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2020.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $72.70 to $73.165, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $73.75 to $74.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
100% of the shares subject to the Option vest on the one year anniversary of January 1, 2016. The vesting of shares subject to the Option will accelerate in full upon a "change in control" as defined in the 2013 Equity Incentive Plan.
/s/ Shannon Atchison, Attorney-in-fact
2021-04-19